Alkermes plc. (ALKS)
CashFlow / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-38,654

-5,354

-52,878

-41,990

-96,398

-9,713

-34,444

-32,649

-62,505

-9,789

-36,276

-42,999

-68,881

-21,141

-62,687

-47,193

-77,423

-69,382

-81,015

-46,109

-30,657

30,514

-39,956

3,735

-24,354

18,077

-7,762

7,334

2,999

16,258

-16,707

22,433

-63,357

-14,828

-22,255

-13,238

Adjustments to reconcile net loss to cash flows from operating activities:
Depreciation and amortization

20,608

20,512

20,345

19,914

19,642

25,902

26,267

25,769

25,722

25,218

25,036

24,506

23,763

24,651

23,819

23,083

22,703

21,781

20,707

20,621

22,487

25,368

25,233

24,933

22,553

23,364

23,674

23,727

18,321

18,601

18,811

18,018

20,633

20,874

4,469

1,908

Share-based compensation expense

19,813

21,387

26,729

28,245

24,616

29,314

25,068

30,933

20,042

20,581

19,488

22,679

21,169

19,783

23,726

26,631

24,256

22,868

35,267

21,877

17,329

13,339

13,482

19,338

13,420

10,391

14,209

8,809

7,881

8,226

10,447

8,162

7,083

9,031

7,052

5,660

Deferred income taxes

3,665

2,706

-624

824

-3,225

6,744

511

7,469

-4,101

19,153

-5,056

-5,648

-1,215

2,856

-3,655

16,547

-25,437

-72,653

13,449

17,323

4,301

-37,923

8,067

15,580

-4,916

16,909

-317

-1,199

-533

-636

-631

-313

-

-

-

-

Change in the fair value of contingent consideration

6,800

5,000

1,300

-6,500

-22,600

-2,300

4,200

-19,600

-1,900

5,700

13,600

700

1,600

4,800

-1,000

2,200

1,900

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Impairment of long-lived assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,346

-

-

-

-

-

-

-

Loss on debt refinancing

-

-

-

-

-

0

0

0

-2,298

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-7,541

-

-

-

-

-

-

-

Payment made for debt refinancing

-

-

-

-

-

0

0

411

1,840

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Excess tax benefit from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-889

512

-268

4,874

-4,241

16,311

11,762

4,744

9,923

15,460

-179

7,163

2,938

1,239

7,217

4,513

3,967

282

105

-

-

-

-

Prepayment penalty in connection with debt refinancing

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

3,733

-

-

-

-

-

-

-

Other non-cash charges

283

490

-585

-441

1,116

-230

-189

1,323

75

114

-175

1,909

1,623

1,035

758

471

672

831

1,059

-394

-145

-729

-44

6,263

3,702

-7,633

1,008

765

795

518

2,613

1,772

1,678

1,945

849

-130

Changes in assets and liabilities:
Receivables

-10,370

6,852

-10,992

38,415

-69,411

41,310

-4,318

41,070

-19,430

26,055

7,828

23,221

-14,615

13,656

-7,562

45,195

-15,673

14,500

5,204

6,323

-9,572

7,859

4,376

16,162

-11,000

13,706

-10,130

5,958

4,785

17,837

-33,658

39,275

-8,036

22,783

-12,348

11,615

Contract assets

5,813

8,363

-7,667

4,243

217

-5,246

-1,105

-11,488

16,959

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory

6,842

2,753

6,396

2,228

1,700

69

514

1,651

431

8,348

7,258

13,852

733

9,225

3,911

5,263

7,982

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid expenses and other assets

-13,615

3,904

-1,383

-806

69

2,699

1,676

2,505

-890

7,562

-3,630

2,673

2,901

13,904

-12,298

9,739

3,669

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Right-of-use assets

-3,926

-2,093

-2,077

-2,098

-2,131

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Inventory, prepaid expenses and other assets

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-6,530

-3,991

-3,021

-

-1,940

6,036

13,678

2,639

1,494

2,212

-1,176

4,642

2,869

242

-3,173

-3,869

13,839

-1,918

Accounts payable and accrued expenses

-51,254

14,305

30,460

5,970

-15,888

33,840

15,523

11,499

-14,123

29,228

30,030

15,130

-1,730

19,037

14,130

13,383

-680

29,864

25,153

31,441

-10,303

31,793

21,410

6,777

-3,084

23,853

1,940

-9,667

26,596

10,232

1,404

-18,826

-8,419

50

27,155

-3,234

Contract liabilities

-859

15,848

-738

305

725

767

1,142

1,098

245

-345

-629

-368

-105

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Operating lease liabilities

-2,378

-2,272

-2,252

-2,296

-2,297

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

397

-481

-442

543

-384

-460

-328

-389

697

-339

-965

3,381

766

-96

-878

-413

-5,731

3,671

4,670

1,209

-285

474

Other long-term liabilities

48

387

-3,908

1,774

1,765

4,675

569

1,083

2,669

-586

1,646

2,786

2,248

81

1,807

810

1,889

2,233

467

446

146

3,174

-2,886

3,293

13

-296

453

-1,539

1,091

-141

2,362

6

-

-

-

-

Cash flows (used in) provided by operating activities

-40,272

42,070

30,972

-23,177

22,212

60,513

33,480

32,126

-26,838

35,909

19,479

-22,451

-13,747

7,558

14,732

-28,878

-57,214

2,415

-29,446

-15,406

2,077

13,643

-7,809

8,777

-3,472

38,106

41,368

12,747

55,304

26,199

49,747

-4,699

15,280

-2,208

2,703

-18,257

CASH FLOWS FROM INVESTING ACTIVITIES:
Additions of property, plant and equipment

19,799

31,970

19,430

15,903

23,639

17,590

16,421

16,935

18,485

17,818

12,826

11,274

9,382

9,870

11,507

10,271

12,009

16,148

11,974

14,045

10,710

13,325

8,888

5,753

5,685

9,856

5,573

3,625

8,259

2,752

4,473

6,733

8,129

5,205

2,730

924

Proceeds from the sale of equipment

3

0

609

206

85

79

5

99

324

112

43

4

3

94

19

74

7

354

141

-1

41

-

-

-

-

46

0

6

119

57

-1

18

32

0

0

3

Proceeds from contingent consideration

-

0

0

5,000

5,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of investments

27,212

135,769

19,940

19,682

102,127

90,124

168,959

102,649

35,995

142,486

128,672

130,393

30,161

78,387

127,090

111,094

58,528

158,526

80,710

152,400

117,047

92,353

116,899

81,714

351,489

81,555

20,906

33,182

142,437

62,290

58,597

40,621

68,907

24,521

67,306

67,495

Sales and maturities of investments

64,500

75,143

70,355

23,126

55,978

99,832

211,523

53,601

79,500

146,002

127,850

135,642

55,000

67,285

185,567

149,729

158,224

132,404

123,026

113,216

98,927

94,614

62,094

99,946

84,500

34,070

25,000

31,400

38,749

34,796

128,706

56,686

55,424

27,241

165,123

75,240

Investment in Synchronicity Pharma, Inc.

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

15,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from the issuance of ordinary shares, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

248,406

-

-

-

-

-

-

-

-

-

-

-

Cash flows provided by (used in) investing activities

17,492

-101,471

31,594

-7,253

-64,703

-7,803

26,148

-65,884

25,344

-14,190

-13,605

-6,021

15,460

-20,878

46,989

28,438

72,694

-42,217

30,509

-2,989

-28,789

46,130

-63,693

26,840

-272,674

-57,295

-2,670

-5,401

-111,828

-31,305

65,635

9,350

-21,580

-2,528

-399,875

6,824

CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from the issuance of ordinary shares under share-based compensation arrangements

3,070

2,544

3,773

2,054

10,554

2,559

1,318

3,836

13,164

5,219

1,894

9,290

7,114

7,562

5,256

3,992

3,498

13,336

9,796

8,239

13,598

20,146

5,610

10,793

11,028

15,134

18,864

15,079

16,847

7,782

8,391

1,340

4,291

1,247

3,502

11,824

Proceeds from the issuance of long-term debt

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2,074

-

-

-

-

-

-

-

Employee taxes paid related to net share settlement of equity awards

7,283

87

156

194

8,880

3,837

43

18

15,724

15

1

3,269

13,148

5,035

0

5,135

3,297

8,839

33

12,339

4,693

-

-

-

-

3,141

6

8,518

5

1,481

0

3,323

154

417

267

2,838

Excess tax benefit from share-based compensation

-

-

-

-

-

-

-

-

-

-

-

-

-

-889

512

-268

4,874

-4,241

16,311

11,762

4,744

9,923

15,460

-179

7,163

2,938

1,239

7,217

4,513

3,967

282

105

-

-

-

-

Principal payments of long-term debt

711

711

711

710

711

-

-

-

-

-

750

750

750

-61,634

61,688

1,687

1,688

1,686

1,689

1,687

1,688

1,686

1,688

1,688

1,688

1,685

1,687

1,688

1,688

1,688

445,793

775

-

-

-

-

Payment made for debt refinancing

-

-

-

-

-

1,389

0

6

737

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Cash flows (used in) provided by financing activities

-4,924

1,746

2,906

1,150

963

-1,989

564

3,102

-3,297

4,454

1,143

5,271

-6,784

-2,541

-55,920

-3,098

3,387

-1,430

24,385

5,975

11,961

28,109

19,362

-3,620

264,909

13,246

18,410

12,090

17,593

8,580

-68,563

-2,653

4,570

830

450,462

8,986

NET DECREASE IN CASH AND CASH EQUIVALENTS

-27,704

-57,655

65,472

-29,280

-41,528

50,721

60,192

-30,656

-4,791

26,173

7,017

-23,201

-5,071

-15,861

5,801

-3,538

18,867

-41,232

25,448

-12,420

-14,751

87,882

-52,140

31,997

-11,237

-5,943

57,108

19,436

-38,931

3,474

46,819

1,998

-1,730

-3,906

53,290

-2,447

SUPPLEMENTAL CASH FLOW DISCLOSURE:
Cash paid for taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-2

10,055

4

11

Non-cash investing and financing activities:
Purchased capital expenditures included in accounts payable and accrued expenses

5,242

-875

11,670

-4,856

7,850

4,603

-129

-270

7,516

5,830

790

-447

4,978

2,124

840

-297

3,099

3,645

-2,071

1,390

3,090

2,792

-800

704

787

785

128

1,056

2,450

840

7

827

1,277

2,008

-589

720